E Fund Management Co., Ltd. Cti Biopharma Corp Transaction History

E Fund Management Co., Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$4.2 - $6.01 $52,840 - $75,611	-12,581 Reduced 16.32%	64,520 $271,000
Q4 2022 Feb 14, 2023	BUY	$4.45 - $6.17 $8,757 - $12,142	1,968 Added 2.62%	77,101 $463,000
Q3 2022 Nov 14, 2022	BUY	$5.36 - $7.43 $133,796 - $185,467	24,962 Added 49.75%	75,133 $437,000
Q2 2022 Aug 15, 2022	BUY	$3.55 - $6.27 $178,107 - $314,572	50,171 New	50,171 $300,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on E Fund Management Co., Ltd. with notifications on news.